Managing Patients with Mixed Phenotype Hereditary Transthyretin Amyloidosis скачать в хорошем качестве

Managing Patients with Mixed Phenotype Hereditary Transthyretin Amyloidosis

In this video capsule, Dr. Diego Delgado discusses how to manage patients with mixed phenotype hereditary transthyretin amyloidosis over the course of their disease from initial symptoms and clinical suspicion, to monitoring patients on treatment. For additional details, please see the related publication by Dr. Delgado and colleagues: https://www.sciencedirect.com/science... Our Guest: Dr. Diego Delgado is the Director of the Cardiac Amyloid Centre and Associate Professor in the Division of Cardiology and Cardiac Transplantation at the University Health Network in Toronto, Ontario. Dr. Diego Delgado graduated in Medicine from the Universidad del Salvador in Buenos Aires, Argentina. He completed his Internal Medicine and Cardiology training in Hospital Espanol in Buenos Aires. Subsequently he completed a research fellowship in cardiac transplantation at Rush Presbyterian St Luke’s Medical Center in Chicago, US and a research/clinical fellowship in heart failure and transplantation at the Toronto General Hospital. Dr. Delgado completed his Maters of Science in Clinical Epidemiology at the University of Toronto and the Leadership Development Program at Rotman School of Management in Toronto. He is the author of more than 100 publications in the area of heart failure, transplantation and mechanical assist devices. His interests are immunologic aspects of heart failure and transplantation and cardio oncology. This video capsule was sponsored by AstraZeneca Canada. If you enjoyed this video, please like and subscribe. For other medical education content, visit our website at: https://www.impactmedicom.com (https://www.impactmedicom.com/).